Diabetes patients will be more satisfied with treatment when they perceive benefits and will continue treatment when physicians keep in contact and point out the progress, says William Polonsky, PhD, CDE, president of the Behavioral Diabetes Institute and associate clinical professor at University of California, San Diego.
Просмотров: 164 AJMCtv
This is a short video on medications used to treat diabetes mellitus by lowering blood glucose levels I created this presentation with Google Slides. Image were created or taken from Wikimedia Commons I created this video with the YouTube Video Editor. ADDITIONAL TAGS: Insulin Bind insulin receptor, activate tyrosine kinase receptor pathway All used for DM1, DM2, GDM Rapid acting insulin: Lispro, Aspart, Glulisine Monomeric insulin analogs â†’ monomers in solution Peak time in 1 hour â†’ no LAG Used for post-prandial glucose control Short acting insulin: regular insulin Same insulin found in human body â†’ dimer/hexamer in solâ€™n Peak in 2 to 4 hours Administered IV for DKA Intermediate acting insulin: NPH Peak in 4 to 10 hours Long acting insulin: glargine, detemir Insulin analog â†’ precipitates at body pH Doesnâ€™t really peak, relatively flat Good for mimicking basal insulin secretion Biguanides METFORMIN Sensitizes to insulin Thought to stimulate liver enzyme AMPK â†’ exact MoA unclear Does not require functioning beta cells More effective in liver than muscle Administered orally Decreases HbA1c by 1-2% Mild weight loss SEs: diarrhea, nausea, vit B12 deficiency, lactic acidosis Contraindicated in kidney/liver/heart failure First line for DM2 Insulin Thiazolidinediones TZDs or -glitazones: pioglitazone and rosiglitazone Sensitizes to insulin â†’ increases number and sensitivity Bind to peroxisome proliferator-activated receptor gamma (PPARÎ³) More effective in periphery (muscle/fat) than liver Does not require functional beta cells Administered orally Decreases HbA1c by 1-1.5% Mild weight gain, increases LDL, expensive, slow onset SEs: weight gain, edema, heart failure, liver toxicity, fractures Safe with renal failure Increases secretion of insulin Decreases HbA1c by 1-2% SEs: weight gain, hypoglycemia, allergies (sulfa drugs) Administered orally Sulfonylureas: tolbutamide, chlorpropamide, glipizide, glyburide, glimepiride Binds to SU on the ATP-activated potassium of beta cells â†’ requires functional beta cells Blocks K channel â†’ Ca influx â†’ activate insulin release Meglitinides: repaglinide, nateglinide Bind to another receptor to block K channel â†’ Ca influx â†’ activate insulin release Faster onset, slower duration, more expensive than sulfonylureas Anti alpha glucosidase Acarbose, miglitol Slows absorption of carbohydrates in the proximal gut Alpha glucosidase is an enzyme that hydrolyzes carbs in the brush border of the GI tract Delays carb breakdown and thus absorption Decreases postprandial hyperglycemia Administered orally Decreases HbA1c by 0.5-1% SEs: flatulence (causes poor adherence), other GI disturbance, liver enzyme elevation Expensive Incretin mimetics Incretins GLP-1 and GIP are gut-derived hormones that: (1) stimulate insulin secretion, (2) inhibit glucagon secretion, (3) slow gastric emptying, and (4) promote satiety Incretin release stimulated by eating GLP-1 receptor analogs: exenatide, liraglutide, dulaglutide Mimick GLP-1 and produce same incretin effects Cause weight loss Dipeptidyl peptidase-4 (DPP4) is the enzyme that breaks down incretins DPP4 inhibitors increase blood conc of incretins -agliptins: sitagliptin, saxagliptin, linagliptin Administered orally Amylin analogues Synthetic amylin analogue: pramlintide Co-secreted with insulin, deficient in diabetes, and has the following effects: (1) inhibit glucagon secretion, (2) slow gastric emptying, (3) promote satiety Decreases HbA1c by 0.5-1% SEs: nausea, hypoglycemia Promotes moderate weight loss Administered orally or subcutaneously Cause weight loss Glycosurics Promote renal excretion of glucose Sodium-glucose cotransporter 2 (SGLT2) is a channel in the proximal tubule responsible for 90% of glucose reabsorption SGLT2 inhibitors: canagliflozin, dapagliflozin, empagliflozin Decreases HbA1c by 0.5-1% SEs: UTIs, vuvlvovaginal candidiasis (vaginal yeast infxns), glycosurea, renal failure, decrease blood pressure, hyperkalemia, dehydration Promotes substantial weight loss Colesevelam Bile acid sequestrant â†’ exact MoA unknown Decreases HbA1c by 0.3-0.4% SEs: constipation, dyspepsia, nausea, hypertriglyceridemia Bromocriptine Dopamine agonist â†’ exact MoA unknown Decreases HbA1c by 0.4-0.5% SEs: headache, dizziness, nausea, vomiting
Просмотров: 44790 MedLecturesMadeEasy
Sherita Golden is working to find out why diabetes raises risk for depression, and vice-versa. The slides for this presentation can be found here: http://www.hopkinsmedicine.org/institute_basic_biomedical_sciences/news_events/Boot_Camp/2016_Weighty_Matters/Golden.pdf
Просмотров: 4085 Johns Hopkins Medicine
Developed and produced for http://www.MDPracticeGuide.com, a CME resource for physicians and healthcare providers. Animation Description: Under normal circumstances, bacterial infection results in the release of chemokines that attract circulating neutrophils to the endothelium. This process is known as chemotaxis. A variety of molecules are expressed on the endothelial cell surface that allow the neutrophil to be captured, then roll along the endothelium, then adhere. Following adherence, the neutrophil migrates into the subendothelial tissue to reach the site of infection. The neutrophil engulfs the bacteria and eliminates them via breakdown within the phagosomes — a process known as phagocytosis. In states of hyperglycemia, chemotaxis is reduced. Adherence is also adversely affected. Phagocytosis is also impaired by hyperglycemia. Hyperglycemia also adversely affects the macrophage system. Under normal circumstances, circulating monocytes are attracted to sites of infection, roll, adhere, and then migrate into the subendothelial space. The monocyte then transforms into a macrophage. which is then activated by cytokines released by the bacteria. The activated macrophage then engulfs the bacteria. However, hyperglycemia results in decreased activation of macrophages, thereby arresting the process of macrophage phagocytosis of bacteria. In addition to affecting neutrophil and macrophage function, hyperglycemia also affects the complement cascade. Under situations of normal glycemia, bacteria can activate the complement cascade. Activation of the complement cascade results in the formation of transmembrane protein channels known as membrane attack complex (MAC) in bacterial membrane. Membrane attack complexes make the bacterial membrane porous and the rapid influx of fluid results in the bacterial cell death. Hyperglycemia inhibits the proper activation of the complement cascade, thereby reducing another pathway of the immune system.
Просмотров: 52880 Mechanisms in Medicine
Even though a person with diabetes might know the literal importance of taking their medication, it can be easy for them to feel overwhelmed or defeated and not feel like the medication is making a difference. Not following your doctor’s medication plan can have dangerous health effects, so it’s important to push past the challenges and focus on what you can do to help yourself. Premier HealthNet’s Dr. Joseph Allen discusses how depression affects medication adherence for people with diabetes. Find more answers to frequently about diabetes at http://www.premierhealthnet.com/familyhealth.
Просмотров: 5220 Premier Health
Based on our Living With Diabetes report, this video presents some of the key findings from the study regarding patient compliance.
Просмотров: 692 ResearchPartnership
Video abstract of original research paper "Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study" published in the open access journal Patient Preference and Adherence by Chew BH, Hassan NH, Mohd-Sidk S. Abstract: Medication adherence, MA, in adults with type 2 diabetes mellitus, T2D, is associated with improved disease control glycated hemoglobin, blood pressure, and lipid profile, lower rates of death and diabetes-related complications, increased quality of life, and decreased health care resource utilization. However, there is a paucity of data on the effect of diabetes-related distress, depression, and health-related quality of life on MA. This study examined factors associated with MA in adults with T2D at the primary care level. This was a cross-sectional study conducted in three Malaysian public health clinics, where adults with T2D were recruited consecutively in 2013. We used the 8-item Morisky Medication Adherence Scale MMAS-8 to assess MA as the main dependent variable. In addition to sociodemographic data, we included diabetes-related distress, depressive symptoms, and health-related quality of life as independent variables. Independent association between the MMAS-8 score and its determinants was done using generalized linear models with a gamma distribution and log link function. The participant response rate was 93.1% 700/752. The majority were female 52.8%, Malay 52.9%, and married 79.1%. About 43% of patients were classified as showing low MA, MMAS-8 score less than 6. Higher income, adjusted odds ratio 0.90, and depressive symptoms, adjusted odds ratio 0.99, were significant independent determinants of medication non-adherence in young adults with T2D. Low MA in adults with T2D is a prevalent problem. Thus, primary health care providers in public health clinics should focus on MA counselling for adult T2D patients who are younger, have a higher income, and symptoms of depression. Read the original article here: http://www.dovepress.com/determinants-of-medication-adherence-among-adults-with-type-2-diabetes-peer-reviewed-article-PPA
Просмотров: 313 Dove Medical Press
Referencias de imágenes de Google: Caballero, S. (22 de Diciembre de 2016). Verde Live. Obtenido de https://www.verdelive.com/noticias/hiperglucemia-azucar-sangre/ Colesterol. (s.f.). Obtenido de https://www.colesterol.top/ Diabetes & Dietas. (s.f.). Obtenido de Síntomas de la diabetes: http://diabetesdietas.com/sintomas-de-la-diabetes/ Diarioenfermo. (1 de Junio de 2015). Obtenido de http://diarioenfermero.es/tiene-la-diabetes-efecto-protector-frente-la-ela/ El blog de Juaristi. (10 de Junio de 2016). Obtenido de https://elblogdejuaristi.com/2016/06/10/seguro-medico-del-imss-para-estudiantes-opera-en-20-estados-del-pais/ El periódico de la farmacia. (19 de Abril de 2017). Obtenido de http://www.elperiodicodelafarmacia.com/articulo/nutricion/nutricionista-clave-evitar-hipertension/20170419082033003653.html Farmacia informativa. (s.f.). Obtenido de Metformina: Qué es, para qué sirve, nombre comercial y más : http://farmaciainformativa.com/c-gastrointestinal/metformina/ Farmalisto. (s.f.). Obtenido de Pioglitazona: https://www.farmalisto.com.mx/diabetes/17019-comprar-pioglitazona-15-mg-caja-con-frasco-con-7-tabletas-precio-7502216796737.html Fichero hematología. (s.f.). Obtenido de http://hemausac2014.blogspot.com/2014/10/celulas-normales.html Grimaldi, P. (12 de Enero de 2017). Vive Healthy. Obtenido de http://www.vivehealthy.com/2017/que-es-la-acantosis-nigricans/ Lux cientifico . (s.f.). Obtenido de https://www.luxcientifico.mx/blog/item/422-una-molécula-se-muestra-eficaz-contra-la-segunda-ceguera-más-frecuente.html Mejor con salud . (s.f.). Obtenido de Pie diabético: prevencíón y cuidados : https://mejorconsalud.com/pie-diabetico-prevencion-y-cuidados/ Primera Plana. (s.f.). Obtenido de DIF Estatal lanzará la campaña “Vida Saludable” en redes sociales: https://www.primeraplana.org.mx/2017/08/24/dif-estatal-lanzara-la-campana-vida-saludable-en-redes-sociales/ Radio Universidad de Guadalajara. (13 de Abril de 2018). Obtenido de http://udgtv.com/radio-udg/crece-numero-pacientes-problemas-renales-la-region/ Rapaport, L. (17 de Octubre de 2017). Oment. Obtenido de ¿Las bombas de insulina pueden funcionar mejor que las inyecciones en los niños con diabetes?: http://oment.uanl.mx/las-bombas-de-insulina-pueden-funcionar-mejor-que-las-inyecciones-en-los-ninos-con-diabetes/ Salut a prop. (s.f.). Obtenido de https://salutaprop.org/es/blog/que-son-las-enfermedades-cardiovasculares Supera tu enfermedad. (s.f.). Obtenido de http://superatuenfermedad.com/c-enfermedades-del-cerebro/enfermedad-cerebrovascular-sus-causas-sintomas-y-mucho-mas/ Web consultas. (s.f.). Obtenido de https://www.webconsultas.com/categoria/salud-al-dia/hipoglucemia Yo autónomo. (s.f.). Obtenido de https://www.yosoyautonomo.com/por-que-necesitas-un-seguro-de-salud-privado-si-eres-autonomo/ Referencias de información: Brunton, S. A., & Polonsky, W. H. (2017). Medication Adherence in Type 2 Diabetes Mellitus: Real-World Strategies for Addressing a Common Problem. Journal of Family Practice, 66(4), S46–S51. Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=122325775&lang=es&site=ehost-live Burgos Peláez, R., & Joaquim, C., & Puiggrós Llop, C., & Chicharro Serrano, L. (2010). Diabetes mellitus tipo 2 crónica. Nutrición Hospitalaria, 3 (1), 35-45. Comité de Educación en Diabetes Fundación IMSS, A. (2007). El papel del derechohabiente en la prevención y control de la diabetes mellitus. Revista Médica del Instituto Mexicano del Seguro Social, 45 (2), 101-103. COSTA GIL, J. E., LINARI, M. A., PUGNALONI, N., ZAMBON, F. G., PÉREZ MANGHI, F., & REZZÓNICO, M. (2017). HIPOGLUCEMIA EN PACIENTES CON DIABETES TIPO 1 Y TIPO 2 EN TRATAMIENTO CON INSULINA. RESULTADOS DEL ESTUDIO HAT EN ARGENTINA. Medicina (Buenos Aires), 77(6), 449-457. Kennedy-Martin, T., Boye, K. S., & Xiaomei Peng. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference & Adherence, 11, 1103–1117. https://doi.org/10.2147/PPA.S136639 Ong, S. E., Koh, J. K., Toh, S. S., Chia, K. S., Balabanova, D., McKee, M., & ... Legido-Quigley, H. (2018). Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review. Plos ONE, 13(3), 1-42. doi: 10.1371/journal.pone.0195086 Gracias por ver.
Просмотров: 1 karina vargas
This animation follows a patient and her physician during a visit in which the doctor diagnoses her with Type 2 diabetes. In this hypothetical case study, a 45-year-old obese woman visits her primary care physician complaining of thirst, frequent urination, blurred vision, and a chronic yeast infection. After obtaining the patient's medical and family history, her doctor suspects type 2 diabetes and performs the necessary tests to confirm the diagnosis. He then outlines her treatment options so that she may return to her everyday activities. This animation was created for Kendall Campbell, M.D., Associate Professor at the Florida State University College of Medicine. It was produced with content direction by Travisha Vaughns, FSU Bridge Student, Class of 2013. All artwork and animation was created by Jodi Slade, Medical Illustrator at the FSU COM Office of Medical Education. All content is copyright 2013 by the Florida State University College of Medicine.
Просмотров: 10580 FSUMedMedia
We've had extremely good results in reversing the complication of DPN, or Diabetic Peripheral Neuropathy, in a handful of patients. Our test subjects range in age and gender and have benefited enormously from rigid adherence to simple changes in lifestyle. http://www.diabetes.org/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002194/ http://drtc.bsd.uchicago.edu/ http://www.mayoclinic.com/health/diabetes/DS01121 http://www.livestrong.com/diabetes/ http://diabetes.niddk.nih.gov/dm/pubs/neuropathies/ http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm http://www.foothealthfacts.org/footankleinfo/diabetic_peripheral_neuro.htm
Просмотров: 40942 mccainisthroughX
Davida F. Kruger, MSN, APN-BC, BC-ADM; Serge Jabbour, MD; and Robert Hood, MD, identify the barriers to patient adherence with insulin when treating diabetes and discuss how simplified regimens might circumvent many of these issues.
Просмотров: 38 MD Magazine
Robert Hood, MD, and Serge Jabbour, MD, discuss the contributing factors to inadequate glycemic control in a patient with diabetes, including clinical inertia, patient adherence, and the stigma surrounding insulin.
Просмотров: 29 MD Magazine
Diabetes is a family crisis! So it should be dealt with full family support & care. Have your family inspire & support you to manage weight, take medicine, track sugar level with CircleCare Family App! This video is useful for: importance of family/social support and impact on adherence to diabetic therapy, diabetes and family, diabetes family support group, psychological impact of diabetes on patient and family, social support and diabetes, importance of family support in chronic illness, the importance of family support, support for diabetes patients
Просмотров: 613 CircleCare - Live Healthy. Earn Rewards.
Recognizing the symptoms of depression. Visit our official website: http://BehavioralDiabetes.org Let's get connected! Facebook: https://www.facebook.com/BehavioralDiabetesInstitute Twitter: https://twitter.com/BDIrealtalk LinkedIn: http://www.linkedin.com/company/behavioral-diabetes-institute
Просмотров: 2548 Behavioral Diabetes Institute
Drugs for Diabetes don't really eliminate the problem. What's worse, these medications have bad side-effects that can affect your short term and long term health. If you're a Type 2 diabetes patient, then this video is a must watch.
Просмотров: 92 Dr. George Kosmides DC
The ALRT remote diabetes monitoring system delivers better health outcomes for your most challenging patients. The current standard for type 2 diabetes care is not working. Typically, after an initial primary care work up the patient is expected to modify their diet and exercise habits. They may also be prescribed a diabetes medication. And they are given a blood glucose meter and a logbook to record their readings once or more times each day. After three months or so the patient comes back to the office and the medical team reviews the progress. But in far too many cases, there is no progress. That’s because most patients with type-2 diabetes ignore their prescribed care plan According to a 2014 study, only 20% of patients with type 2 diabetes were adherent to their prescribed treatment. And patients at greatest risk for diabetes complications are the least likely to self- monitor their blood glucose levels. This is one reason why the cost of diabetes care in the United States totals two hundred forty five billion dollars annually. An employee with diabetes complications can cost a business nearly 4 times as much as an employee without diabetes. And today, up to 40 percent of the health claims at large employers are due to diabetes and related co-morbidities. But there’s a better way to improve adherence and outcomes. The ALRT system is an FDA-cleared, HIPAA compliant, web-based remote Chronic Care Management platform. In clinical trials and in real world settings, ALRT can improve adherence and increase quality scores for diabetes care. It is also qualifies for Medicare’s new Chronic Care Management reimbursement. Here’s how it works. First, the patient takes regular readings as prescribed . . . and then uploads the data to the secure ALRT platform. An on-staff ALRT Diabetes Data Monitor reviews the data against protocols set by the physician. If the data show a divergence with the established protocol, ALRT sends a notice to the physician or care team. The physician can then make changes to the patient’s care plan or intervene if necessary. The patient then takes corrective action as prescribed by the doctor. So, why does this work when conventional care has failed? Because with the ALRT system the patient knows he or she is being monitored. The data cannot be fabricated. And importantly the patient feels invested in the care plan. In clinical trials, internet-based glucose monitoring was tested against conventional care on type-2 patients with A1C levels over eight percent. After six months the A1C levels of the monitored patients were more than a percentage point lower . . . while the group receiving conventional care were unchanged. According to the CDC, a one percent drop in A1C can reduce costly complications from diabetes by 40%. Significantly, six months after the monitoring ended A1C levels in the intervention group went right back to where they had been. That’s because conventional care isn’t working. And remote monitoring makes a meaningful difference. Let us show you how you can improve outcomes and deliver affordable adherence with the ALRT remote monitoring system for diabetes. Call us for a demonstration at (816) 807-7054.
Просмотров: 250 ALRTechnologies
www.AcuPain Therapy.com This elderly lady was undergoing treatment for diabetes mellitus since last 10 years. In spite of drugs she was taking her fasting blood sugar was maintained at 250 mg% from initial 350 mg%. With Dr Pardeshi Acupuncture Dr Pardeshi Acupuncture Pain Therapy she is maintaining fasting BSL at 125 mg%
Просмотров: 58 Dr Pardeshi MD
The statistics surrounding Type 2 Diabetes are staggering: nearly 26 million children and adults in America have diabetes - 90 to 95 percent of those diagnosed have type 2 Diabetes. This means nearly 10 percent of the American population has this condition including 25 percent of seniors. According to the National Institutes of Health, 18.7 percent of non-Hispanic blacks, ages twenty and older, have diagnosed and undiagnosed diabetes. ThatÕs nearly 5 million people. And approximately 10.4 of Hispanics over 20 years of age have diagnosed diabetes. Controlling Type 2 Diabetes depends a great deal on a patientÕs compliance not only in taking medications, but with lifestyle modifications as well. In this program, experts will discuss the significant role of diet, exercise and lifestyle changes in treating and monitoring Type 2 Diabetes. If these efforts do not help keep blood sugar at normal or near-normal levels, patients will likely be prescribed medication to help them in this crucial effort.
Просмотров: 113 Webd.Tv
http:/internationalforum.bmj.com Increasing diabetic education for adherence to dietary management - video poster by Rita Armstrong, Dallas Nursing Institute Join us this year by registering at http:/internationalforum.bmj.com
Просмотров: 126 International Forum on Quality and Safety in Healthcare
One of the challenges in treating a chronic disease such as diabetes is pill adherence. It should be effective, well-tolerated oral antihyperglycemic agent. It should be effective in lowering HbA1c levels with a favorable safety profile. It has the potential to improve patient adherence, which might translate into better glycemic control and disease outcomes. So, a once-weekly drug may be a convenient. After 24 weeks of treatment, patients who received had a significantly greater mean reduction in HbA1c from baseline. The major treatment effect was observed by week 12. It should not associated with symptomatic or severe hypoglycemia or any appreciative change in weight. Merck is now conducting 10 phase 3 clinical trials in approximately 8000 patients with type 2 diabetes, according to a company statement. Youtube Channel: https://www.youtube.com/user/drzulfiquar Facebook: https://www.facebook.com/drzulfiquarahmed Google+: https://plus.google.com/+ZulfiquarAhmed Website: http://www.drzulfiquar.com
Просмотров: 501 Dr. Zulfiquar Ahmed
This webinar examines how on an average, one-third to one-half of the patients for whom appropriate therapies are prescribed do not receive the full benefit from the prescribed therapeutic regimen because of inadequate adherence. Our experts will explore how non-adherence is especially high among patients with chronic diseases (including diabetes mellitus) that typically require long-term and sometimes complex treatment regimen to control symptoms and prevent complications.
Просмотров: 50 primarycare matters
Visit us (http://www.khanacademy.org/science/healthcare-and-medicine) for health and medicine content or (http://www.khanacademy.org/test-prep/mcat) for MCAT related content. These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Matthew McPheeters. Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-endocrine-system-diseases/rn-diabetes/v/treating-type-ii-diabetes-pharmacology?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-endocrine-system-diseases/rn-diabetes/v/diagnosing-diabetes?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States License (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/). About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Просмотров: 87065 khanacademymedicine
How live better with a diabetes ? With a clear organization of cares !!! MABOX DIABETE, patented innovation to helpful everyday people who needs injection of insulin. Only 3 easy steps to insure a good adherence of treatment. Already recommended by medical staff, MABOX DIABETE is very easy to use by anyone. Compatible for Pump and Insulin Pens accessories. Up to 12 hours of cold with professional grades. MABOX DIABETE = Reduce the stress = Improve adherence of treatment in safety condition.
Просмотров: 1194 MABOX DIABETE INNOVATION SPECIAL DIABETE
The objectives of this talk are to: 1) summarize the evidence-base on psychological variables that may affect teens' type 1 diabetes self-care; 2) understand behavioral mechanisms that may impede self-care in adolescents; and 3) recognize the critical elements of effective behavioral interventions targeting improved self-management. It is intended for people who are not as familiar with the adolescents type 1 diabetes psychosocial literature, including studies on improving adherence and diabetes control.
Просмотров: 689 Div54SPPChannel
http://www.medcominc.com TO ORDER, PLEASE CALL (800) 541-0253 http://www.medcomrn.com In the United States, diabetes has become an epidemic. More than 25.6 million people — 11.3% of our population — are estimated to be affected. Just over one-fourth of these individuals are over the age of 65 while less than 0.26% are younger than 20. And, it is estimated that another 7 million people are unaware they are affected. This course is designed to provide nurses in clinical practice with an overview of diabetes, risk factors and signs and symptoms associated with a diagnosis of diabetes, factors to consider when providing care to a patient diagnosed with diabetes and practical steps that can be taken to encourage adherence to treatment regimens. After completing this course, the learner should be able to: • Define the types of diabetes. • Identify signs, symptoms and risk factors for diabetes. • Describe the roles of clinical and home glucose tests. • Describe the importance of periodic and ongoing reassessment. • Describe conditions to look for when assessing patients with diabetes.
Просмотров: 40 Medcom Trainex
This program is designed to provide nurses in clinical practice with an overview of diabetes, risk factors, signs and symptoms associated with a diagnosis of diabetes, factors to consider when providing care to a patient diagnoses with diabetes, as well as practical steps that can be taken to encourage adherence to treatment regimens.
Просмотров: 20 Kineticstreaming
In this on-demand webcast activity, Dr. Luigi Meneghini discusses best practices for overcoming barriers to the initiation of long-acting insulin therapy for the management of diabetes. Earn credit for this activity at the following location: https://naccme.com/program/2017-726-6 © 2017 North American Center for Continuing Medical Education, LLC, an HMP Communications Holdings Company.
Просмотров: 29 NACCME
The role of depression in diabetes and self-care. Visit our official website: http://BehavioralDiabetes.org Let's get connected! Facebook: https://www.facebook.com/BehavioralDiabetesInstitute Twitter: https://twitter.com/BDIrealtalk LinkedIn: http://www.linkedin.com/company/behavioral-diabetes-institute
Просмотров: 838 Behavioral Diabetes Institute
Diabetes Management System A seamless computer software for private practices that specialize in diabetes management and/or see a large number of patients living with diabetes, medical schemes, and managed care organization; designed to record, save, analyze, manage, and exchange health information electronically in order to; Provide accurate, up-to-date, and complete information about patients at the point of care. The main objective is to; - Prevent and/or delay the onset of diabetes complications - Improve adherence to medication and suggested lifestyle changes - Prolong lives - Improve quality of life - Reduce hospitalization and readmissions - Reduce diabetes management related costs - Improve patient education and self-management FEATURES: - Electronic Diabetes Medical Records - Electronic Booking system and records - Diabetes routine visits, notes, and test records - Dietician - Diabetes Nurse Educator - Full Blood Count - HbA1c - Lipids Profile - Ophthalmology - Podiatry - Routine examination - Kidney Function test - And more…(fully customizable) - e-Scripting - Treatment Plan Reports - Individualized records and reminders - Stock Management - Fully customizable
Просмотров: 13 AFLU MED HEALTHCARE
In this clip, William Polonsky, PhD, CDE, president of the Behavioral Diabetes Institute and associate clinical professor at University of California, San Diego, discusses advise for pharmacists looking to motivate patients to stay on their insulin.
Просмотров: 93 Pharmacy Times TV
Kalonji se Sugar Ka Ilaj | Diabetes Treatment in Urdu | Sugar ka Desi Ilaj Urdu Hindi شوگر کا علاج https://goo.gl/ubUUMJ Adherence to a diabetic diet is a critical aspect of controlling blood sugar in people with diabetes. When considering an ideal diabetic diet, a number of factors must be taken into consideration, including the amount and type of carbohydrates consumed as well as the amount of fiber, fat, and protein contained in foods. Glycemic index and glycemic load are further considerations. Foods with low glycemic index and load raise blood sugar more slowly than high glycemic index/load foods. Glycemic index refers to a standardized measurement, while glycemic load takes a typical portion size into account. Please Subscribe Fitness Factory Channel Thanks for Watching Video...
Просмотров: 66576 Fitness Factory
Diabetes Treatment Advances Afrezza, Lucentis, Stem Cells There are a number of treatments available to help you manage and control your diabetes. Everybody is different, so treatment will vary depending on your own individual needs. If you have Type 1 diabetes, you will need to treat the condition with insulin, whereas if you have Type 2, you may initially be able to manage your condition with diet and exercise. Your GP or a healthcare professional can help you find the right treatment to suit you and your lifestyle. Type 2 diabetes is a progressive condition, and over time you may need medication to help manage your blood sugar levels. Find out more about diabetes tablets and medication. Everyone with Type 1 diabetes, and some people with Type 2 diabetes, need to take insulin to control blood sugar levels (also called blood glucose levels). ?Find out more about insulin. An alternative to injecting with a pen, an insulin pump can help improve diabetes control and give you more flexibility when managing the condition.? Find out more about insulin pumps. If you have Type 1 diabetes, an islet cell transplant may be available to you, and could stop you experiencing severe hypos. Find out more about islet cell transplants. For many years, a variety of obesity surgery procedures applied to the stomach or intestine have been used as a method of losing weight. Recently, various studies have found that this can help to put Type 2 diabetes into remission. Find out more about weight loss surgery. Adherence to a diabetic diet is a critical aspect of controlling blood sugar in people with diabetes. When considering an ideal diabetic diet, a number of factors must be taken into consideration, including the amount and type of carbohydrates consumed as well as the amount of fiber, fat, and protein contained in foods. Glycemic index and glycemic load are further considerations. Foods with low glycemic index and load raise blood sugar more slowly than high glycemic index/load foods. Glycemic index refers to a standardized measurement, while glycemic load takes a typical portion size into account. The total daily calories are evenly divided into three meals (with snacks for youth with type 1 diabetes). Over the past two years the ADA has lifted the absolute ban on simple sugars for people with diabetes. Small amounts of simple sugars are now allowed when consumed with a complex meal. Weight reduction and exercise are important treatments for type 2 diabetes. Weight reduction and exercise increase the body's sensitivity to insulin, thus helping to control blood sugar elevations. WARNING: All the information below applies to patients who are not pregnant or breastfeeding. At present the only recommended way of controlling diabetes in women who are pregnant or breastfeeding is by diet, exercise, and insulin therapy. You should speak with your health-care professional if you are taking these medications, are considering becoming pregnant, or if you have become pregnant while taking these medications. A preferred drug can provide more than one benefit (for example, lower blood sugar and control cholesterol). Cost of drug therapy is relatively small compared to costs of managing chronic complications associated with poorly controlled diabetes. Varying combinations of medications can control diabetes. Newer medications allow tailoring of treatment options to meet individual needs. Not every patient with type 2 diabetes will benefit from every drug, and not every drug is suitable for each patient. Patients with type 2 diabetes should work closely with their health-care professionals to achieve an approach that provides the greatest benefits while minimizing risks and adverse events. People with diabetes must remember the importance of diet and exercise. Control of diabetes begins with a healthy lifestyle, regardless of prescribed medications. Meglitinides is a class of drugs that work by promoting insulin secretion from the pancreas, binding to a different site on the same channel complex regulated by sulfonylureas. Unlike the sulfonylureas which last longer in the body, repaglinide (Prandin) and nateglinide (Starlix) are very short acting, with peak effects within one hour. For this reason, they are given up to three times a day just before meals. Since these drugs increase circulating insulin levels they may cause hypoglycemia. Literature suggests meglitinides cause hypoglycemia less frequently than sulfonylureas. diabetes treatment, type 2 diabetes, diabetes mellitus, diabetes symptoms, diabetes cure
Просмотров: 12622 PineAppleExpress7
For other AJMCtv interviews, click here: http://www.ajmc.com/ajmc-tv/interviews
Просмотров: 41 AJMCtv
Speaker: Simon Heller, BA, DM, FRCP The Challenge of Hypoglycaemia in Diabetes: Risks, Consequences and Management Webinar Description: Hypoglycemia is a serious, acute complication of diabetes, and the occurrence of hypoglycemia is linked to increased morbidity, mortality, and cost. Hypoglycemia and the fear of hypoglycemia by patients and healthcare providers are primary barriers to reaching optimal glycemic control, and minimizing hypoglycemia is thought to increase adherence and satisfaction with treatment regimens. Simon Heller, BA, DM, FRCP discusses hypoglycemia, fear of hypoglycemia, and related treatment strategies.
Просмотров: 8 LifeScan Diabetes Institute
When longtime Kelsey-Seybold patient Leallia King was diagnosed with diabetes, her doctor, Chief of Family Medicine Patrick Carter, M.D. helped her manage her treatment, resulting in favorable results in her care. Certification through the National Committee for Quality Assurance (NCQA), is achieved as the result of a comprehensive, individualized review process that verifies a physician's adherence to national standards of excellence in caring for patients diagnosed with diabetes. Of the more than 100 physicians in Texas who have earned NCQA certification, Kelsey-Seybold's 72 doctors represent the most for any health care provider in the state. Learn more about our NCQA-certified physicians: http://www.kelsey-seybold.com/health-resources/health-features/pages/excellence-in-diabetes-care.aspx
Просмотров: 758 Kelsey- Seybold
Dr. Mark Peyrot discusses helping patients start insulin therapy and providing continuing support to adhere to an insulin regimen. Learn more about V-Go and order a FREE demo kit to see how insulin delivery can be worn like a patch at www.go-vgo.com. V-Go Important Risk Information: If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.
Просмотров: 295 V-Go Simple Insulin Patch
Strata Rx 2013 in Boston MA, Sept 27, 2013
Просмотров: 37 Tim Darling
A third of patients prescribed a common diabetes drug do not take their medication because of the side effects, researchers have warned.Metformin, which costs as little as 1p per pill, is the most commonly prescribed drug for type two diabetes.Records do not reveal how many of the 3.4million people in the UK with type two diabetes are given the drug, but every year nearly 19million prescriptions are issued in England alone.Metformin help diabetics control their condition by reducing the levels of sugar produced by the liver.For many people it is an essential - yet University of Surrey researchers found 30 per cent of prescribed doses are never taken.The researchers, whose findings are published in the journal Diabetes, Obesity and Metabolism, believe the side effects are to blame.Other diabetes drugs called gliclazide are only shunned by 23 per cent of patients, 20 per cent do not take prescribed pioglitazone.Metformin commonly causes gastrointestinal symptoms such as diarrhoea and flatulence.Researcher Dr Andy McGovern, whose team tracked 1.6million people with type two diabetes, said: ‘The importance of diabetes patients taking their prescribed medication cannot be underestimated.‘A failure to do so can lead to complications in their condition including eye disease and kidney damage.‘Medication which is not taken does no good for the patient but still costs the NHS money so this is an important issue.‘We have known for a long time that a lot of medication prescribed for chronic diseases never actually get taken.‘What this latest research suggests is that patients find some of these medication classes much easier to take than others.’He added: ‘I urge anyone who is struggling to take their medication as prescribed, whether this is because of side effects or because the schedule is too complicated, to discuss this openly with their doctor or nurse.‘Fortunately for type two diabetes we have lots of treatment options and switching to a different medication class which is easier to take could provide an easy way to improve adherence.‘I would also encourage doctors and nurses to actively ask their patients about medication adherence.’ AutoNews- Source: http://www.dailymail.co.uk/news/article-5189313/Up-diabetics-wont-pills.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490
Просмотров: 21 US Sciencetech
Why So Many People with Diabetes Stop Taking Metformin Researchers say metformin has the lowest adherence rate of any major diabetes drug. People who take the number one most commonly prescribed drug for diabetes are also the most likely to stop taking their medication. However, the toll it takes on the digestive system may prevent many people with diabetes from taking it for more than a week or two. While some degree of metformin's side effects can't be helped, Marcey Robinson, MS, RD, CSSD, CDE, BC-ADM, co-founder of Achieve Health & Performance, says there are actually several things doctors can do when prescribing metformin to ensure patient adherence. How to best use metformin "For some patients, the doctor might also think that having a bigger boost of the medication all at once is going to help a patient who is struggling with high blood sugars after a meal. But that's really not how metformin is expected to work in the body," she added. Gretchen Becker, author of "The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed," has been taking metformin for more than 20 years after receiving a diagnosis of type 2 diabetes in 1996. Personal stories from patients Corinna Cornejo, who received a diagnosis of type 2 diabetes in 2009, told Healthline that her digestive woes didn't start until she'd been taking metformin for more than a year. "Taking metformin with a GLP-1 drug means they actually complement each other, balancing out those side effects." Although there are many diabetes drugs on the market today, doctors will likely push metformin first. Educating patients But there's another pertinent reason Robinson believes so many people stop taking their diabetes medication: lack of education. Teaching patients why they're taking a certain medication, how to take it, and how it's going to improve their health is key, insists Robinson.
Просмотров: 420 Gnews Health
John Buse, MD, PhD, from the University of North Carolina, addresses hypoglycemia in type 2 diabetes patients, and how it may affect adherence as well as weight. Provided by the Institute for Diabetes, Obesity, and Cardiovascular Disease (iDOC), a free resource for continuing medical education and other tools for medical professionals focused on the treatment of these three related conditions. Visit www.idoc.org for more information.
Просмотров: 698 iDOCpodcasts
Treatments for depression in those with diabetes Visit our official website: http://BehavioralDiabetes.org Let's get connected! Facebook: https://www.facebook.com/BehavioralDiabetesInstitute Twitter: https://twitter.com/BDIrealtalk LinkedIn: http://www.linkedin.com/company/behavioral-diabetes-institute
Просмотров: 871 Behavioral Diabetes Institute
University of Arizona, Southern Arizona Limb Salvage (SALSA) and its engineering branch (interdisciplinary Consortium on Advanced Motion Performance; iCAMP) are working together to translate the innovation in wearable technologies and mHealth for diabetes care from surgery management to patient adherence in wearing offloading boots.
Просмотров: 471 Bijan Najafi
To learn more visit: http://www.AnimatedDiabetesPatient.com Patients with diabetes should understand how safe their medications are, how they work in the body, what side-effects to expect, and what to look out for in terms of treatment.
Просмотров: 53 Animated Diabetes Patient
The relation of periodontitis with diabetes mellitus has been researched for many years and is now well established that hyperglycaemia could influence progression of periodontal disease. There is also a growing body of evidence implicating chronic periodontitis in affecting glycaemic control and aggravating complications in diabetes. Script/Illustration/Narration: Sanketh MDS Sound Effects: https://www.freesound.org https://www.youtube.com/audiolibrary/soundeffects You could also get access to: i)"Premium" videos(not on YouTube), ii) Illustrated scripts of all our videos(Transcripts), and iii) thousands of Multiple Choice Questions on our website hackdentistry.com! Check them out! Check out our free trial: https://hackdentistry.com/hackdentistry-subscription-plan/ Website: https://hackdentistry.com Watch more videos: https://hackdentistry.com/course-videos/ Subscribe: https://www.youtube.com/c/HackDentistry?sub_confirmation=1 HackDentistry is an edtech company that aims make learning dentistry fun,engaging and light hearted. 1) It focuses on helping students understand and retain core concepts in dentistry through highly visual sketch/whiteboard style video animations. 2) The platform helps improve exam performance by providing numerous revision notes and allowing students to test themselves using thousands of practice questions (multiple choice format). 3) It also provides for a crowd-sourcing platform, in which students can create their own notes and multiple choice questions and share it with their peers and other users in the platform, encouraging active learning. Facebook: https://www.facebook.com/hackdentistry Twitter: https://twitter.com/hckdentistry
Просмотров: 2166 Hack Dentistry